In vitro models mimicking in-patient conditions have the potential to yield exciting opportunities for antibiotic research and revitalize future antibiotic discovery and development.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effect of host microenvironment and bacterial lifestyles on antimicrobial sensitivity and implications for susceptibility testing
npj Antimicrobials and Resistance Open Access 21 May 2025
-
Echinacoside reduces intracellular c-di-GMP levels and potentiates tobramycin activity against Pseudomonas aeruginosa biofilm aggregates
npj Biofilms and Microbiomes Open Access 07 March 2025
-
Metabolic engineering approaches for the biosynthesis of antibiotics
Microbial Cell Factories Open Access 31 January 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
118,99 € per year
only 9,92 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Antimicrobial Resistance Collaborators Lancet 399, 629–655 (2022).
Lewis, K. Cell 181, 29–45 (2020).
Luepke, K. H. et al. Pharmacotherapy 37, 71–84 (2017).
Miethke, M. et al. Nat. Rev. Chem. 5, 726–749 (2021).
Bjarnsholt, T. et al. Lancet Infect. Dis. 22, e88–e92 (2022).
Cain, A. K. et al. Nat. Rev. Genet. 21, 526–540 (2020).
Cornforth, D. M. et al. Proc. Natl Acad. Sci. USA 115, E5125–E5134 (2018).
Sommer, M. O. A., Munck, C., Toft-Kehler, R. V. & Andersson, D. I. Nat. Rev. Microbiol. 15, 688–695 (2017).
Mustafa, M. H. et al. Eur. Respir. J. 49, 1601847 (2017).
Cornforth, D. M., Diggle, F. L., Melvin, J. A., Bomberger, J. M. & Whiteley, M. mBio 11, e03042–19 (2020).
Ersoy, S. C. et al. eBioMedicine 20, 173–181 (2017).
Aguilar, C. et al. Exp. Mol. Med. 53, 1471–1482 (2021).
Sharma, K. et al. eLife 10, e66481 (2021).
Pleguezuelos-Manzano, C. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.03.11.532178 (2023).
Weber, B. S. et al. Cell Rep. 32, 107927 (2020).
Acknowledgements
This work was supported by the National Centre of Competence in Research AntiResist funded by the Swiss National Science Foundation (grant number 180541).
Author information
Authors and Affiliations
Contributions
J.S., M.P., D.B., U.J. and C.D. wrote the paper and prepared the figure, with input from all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Microbiology thanks Ruggero La Rosa and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Sollier, J., Basler, M., Broz, P. et al. Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions. Nat Microbiol 9, 1–3 (2024). https://doi.org/10.1038/s41564-023-01566-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-023-01566-w
This article is cited by
-
Metabolic engineering approaches for the biosynthesis of antibiotics
Microbial Cell Factories (2025)
-
Effect of host microenvironment and bacterial lifestyles on antimicrobial sensitivity and implications for susceptibility testing
npj Antimicrobials and Resistance (2025)
-
Decoding host-microbe interactions with engineered human organoids
The EMBO Journal (2025)
-
Echinacoside reduces intracellular c-di-GMP levels and potentiates tobramycin activity against Pseudomonas aeruginosa biofilm aggregates
npj Biofilms and Microbiomes (2025)
-
A spotlight on the tuberculosis epidemic in South Africa
Nature Communications (2024)
